Wells Fargo & Company Jan One Inc. Transaction History

Wells Fargo & Company

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$0.5 - $2.88 $1 - $5	2 Added 8.33%	26 $0
Q4 2023 Feb 09, 2024	BUY	$0.3 - $0.66 $2 - $5	8 Added 50.0%	24 $0
Q3 2023 Nov 13, 2023	SELL	$0.41 - $1.07 $2 - $6	-6 Reduced 27.27%	16 $0
Q2 2023 Aug 15, 2023	BUY	$0.87 - $1.2 $2 - $3	3 Added 15.79%	22 $0
Q1 2023 May 12, 2023	BUY	$1.07 - $1.77 $1 - $1	1 Added 5.56%	19 $0
Q4 2022 Feb 13, 2023	BUY	$1.37 - $2.41 $2 - $4	2 Added 12.5%	18 $0
Q3 2022 Nov 14, 2022	SELL	$2.13 - $3.43 $2 - $3	-1 Reduced 5.88%	16 $0
Q2 2022 Aug 12, 2022	BUY	$2.0 - $4.07 $2 - $4	1 Added 6.25%	17 $0
Q3 2021 Nov 15, 2021	BUY	$5.98 - $8.0 $11 - $16	2 Added 14.29%	16 $0
Q2 2021 Aug 16, 2021	BUY	$5.9 - $9.46 $11 - $18	2 Added 16.67%	14 $0
Q1 2021 May 13, 2021	BUY	$4.47 - $12.99 $17 - $51	4 Added 50.0%	12 $0
Q4 2020 Feb 09, 2021	SELL	$3.5 - $5.44 $7 - $10	-2 Reduced 20.0%	8 $0
Q3 2020 Nov 05, 2020	BUY	$3.07 - $7.79 $12 - $31	4 Added 66.67%	10 $0
Q1 2020 May 14, 2020	BUY	$2.05 - $4.12 $12 - $24	6 New	6 $0

630K

Ticker JAN
Exchange NASDAQ
Sector Industrials
Industry Waste Management
Shares Outstandng 3,150,230
Market Cap $6.49M
Description
JanOne Inc., a clinical-stage biopharmaceutical company, focuses on identifying, acquiring, licensing, developing, partnering, and commercializing novel, non-opioid, and non-addictive therapies to address the unmet medical need for the treatment of pain and addiction. It operates through three segments: Biotechnology, Recycling, and Technology. ...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.